We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Bayer Ag (BAYN) NPV (CDI)

Sell:€18.82 Buy:€18.88 Change: €0.13 (0.68%)
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Sell:€18.82
Buy:€18.88
Change: €0.13 (0.68%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Sell:€18.82
Buy:€18.88
Change: €0.13 (0.68%)
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.

Contact details

Address:
Kaiser-Wilhelm-Allee 1
LEVERKUSEN
51373
Germany
Telephone:
+49 (214) 301
Website:
https://www.bayer.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BAYN
ISIN:
DE000BAY0017
Market cap:
€18.56 billion
Shares in issue:
982.42 million
Sector:
Pharmaceuticals
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Norbert Winkeljohann
    Chairman of the Supervisory Board
  • William Anderson
    Chairman of the Management Board, Chief Executive Officer
  • Heike Hausfeld
    Vice Chairwoman of the Supervisory Board, Employee Representative
  • Wolfgang Nickl
    Chief Financial Officer, Member of the Management Board
  • Nelson Ambrogio
    Head of Radiology Business
  • Stefan Oelrich
    Member of the Management Board, Head of the Pharmaceuticals Division
  • Haike Prinz
    Member of the Management Board, Chief Talent Officer and Labor Director
  • Rodrigo Santos
    Member of the Management Board, Head of the Crop Science
  • Julio Triana
    Member of the Management Board, President - Consumer Health Division

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.